Acetaminophen Injection - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The global market for Acetaminophen Injection was estimated to be worth US$ 719.68 million in 2023 and is forecast to a readjusted size of US$ 912.04 million by 2030 with a CAGR of 2.97% during the forecast period 2024-2030.
North American market for Acetaminophen Injection was valued at $ 277.80 million in 2023 and will reach $ 336.17 million by 2030, at a CAGR of 2.37% during the forecast period of 2024 through 2030.
Asia-Pacific market for Acetaminophen Injection was valued at $ 116.09 million in 2023 and will reach $ 160.58 million by 2030, at a CAGR of 3.99% during the forecast period of 2024 through 2030.
Europe market for Acetaminophen Injection was valued at $ 213.91 million in 2023 and will reach $ 272.99 million by 2030, at a CAGR of 3.21% during the forecast period of 2024 through 2030.
The global key companies of Acetaminophen Injection include Hikma, Sandoz, Mallinckrodt, B. Braun Medical Inc, Eugia, Fresenius Kabi, Pfizer, Accord Healthcare, and Terumo, etc. In 2023, the global three largest players hold a share approximately 66.67% in terms of revenue.
This report aims to provide a comprehensive presentation of the global market for Acetaminophen Injection, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Acetaminophen Injection by region & country, by Type, and by Application.
The Acetaminophen Injection market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Acetaminophen Injection.
Market Segmentation
By Company
Mallinckrodt
Sandoz
Pfizer
Fresenius Kabi
Terumo
B. Braun Medical
Eugia
Accord Healthcare
Hikma
Segment by Type
10 mg/ mL
100 mg/mL
150 mg/mL
Segment by Application
Hospital
Clinic
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Russia
Rest of Europe
Latin America & Middle East & Africa
Latin America
Middle East & Africa
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Acetaminophen Injection company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Acetaminophen Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Acetaminophen Injection in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.